Milestone Pharmaceuticals Inc

NASDAQ:MIST   3:59:54 PM EDT
5.49
+0.12 (+2.24%)
Earnings Announcements

Milestone Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/24/2022 11:33 GMT
Milestone Pharmaceuticals Inc (MIST) - Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update.
As of December 31, 2021, Milestone Had Cash, Cash Equivalents, and Short-term Investments of $114.1 Million.
Qtrly Loss per Share $0.40.
Qtrly Net Loss per Share, Basic and Diluted $0.40.
Q1 Earnings per Share View $-0.38 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.